On an expansion spree

Company
23 Sep 2024
5 Min read 
  • Max Healthcare is recommended as a buy with a target price of INR 1,240.
  •  The company has aggressively increased its bed capacity through organic and inorganic means.
  •  MAXHEALT has strategically expanded its presence in the UP market.
  •  The company plans to add 2,400 beds to its total bed capacity.
  •  MAXHEALT has emerged as a dominant player in the UP market with a series of acquisitions.
  •  The company is expected to register a 15% CAGR in EPS over FY23 FY25.
Login / Open Demat Account to read the report

Never Miss Out on Hot Market Updates

Get exclusive market news delivered to your inbox - on priority